Recent advances in the development of dopamine D3 receptor antagonists: a medicinal chemistry perspective. (Q37855718)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425240%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

review article

1 reference

title

Recent advances in the development of dopamine D3 receptor antagonists: a medicinal chemistry perspective (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425240%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425240%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Fabrizio Micheli

1 reference

24 August 2017

publication date

18 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425240%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425240%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425240%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425240%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

1152-1162

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425240%20AND%20SRC:MED&resulttype=core&format=json

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

26 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Dopamine D3 receptor ligands with antagonist properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Interactive SAR studies: rational discovery of super-potent and highly selective dopamine D3 receptor antagonists and partial agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Parallel synthesis and dopamine D3/D2 receptor screening of novel {4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl}carboxamides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

N-(omega-(4-(2-methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as dopamine D2 and D3 receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

ADMET rules of thumb II: A comparison of the effects of common substituents on a range of ADMET parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

In silico human and rat Vss quantitative structure-activity relationship models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

A comparison of physiochemical property profiles of development and marketed oral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Lead- and drug-like compounds: the rule-of-five revolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Effects of two novel D3-selective compounds, NGB 2904 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide] and CJB 090 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide], on the reinforcing and dis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Selective dopamine D3 receptor antagonists: a review 2001-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Fancy bioisosteres: metallocene-derived G-protein-coupled receptor ligands with subnanomolar binding affinity and novel selectivity profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Design and synthesis of a piperazinylalkylisoxazole library for subtype selective dopamine receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Aldehyde Oxidase: An Enzyme of Emerging Importance in Drug Discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Pharmacophore-guided drug discovery investigations leading to bioactive 5-aminotetrahydropyrazolopyridines. Implications for the binding mode of heterocyclic dopamine D3 receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Classification of dopamine antagonists using functional feature hypothesis and topological descriptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Dopamine D3 receptor antagonists as therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Synthesis and SAR of highly potent and selective dopamine D(3)-receptor antagonists: 1H-pyrimidin-2-one derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Synthesis and SAR of highly potent and selective dopamine D(3)-receptor antagonists: Quinolin(di)one and benzazepin(di)one derivatives. herve.geneste@abbott.com

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Synthesis and SAR of highly potent and selective dopamine D3-receptor antagonists: variations on the 1H-pyrimidin-2-one theme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Characterization of the transport, metabolism, and pharmacokinetics of the dopamine D3 receptor-selective fluorenyl- and 2-pyridylphenyl amides developed for treatment of psychostimulant abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Triazolyl azabicyclo[3.1.0]hexanes: A class of potent and selective dopamine D(3) receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Exploration of the amine terminus in a novel series of 1,2,4-triazolo-3-yl-azabicyclo[3.1.0]hexanes as selective dopamine D3 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

N-(4-(4-(2,3-dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with functionalized linking chains as high affinity and enantioselective D3 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

1,1'-Disubstituted ferrocenes as molecular hinges in mono- and bivalent dopamine receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Lack of effect of reserpine-induced dopamine depletion on the binding of the dopamine-D3 selective radioligand, [11C]RGH-1756.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Synthesis and evaluation of 18F-labeled dopamine D3 receptor ligands as potential PET imaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Design, synthesis, and binding affinities of potential positron emission tomography (PET) ligands for visualization of brain dopamine D3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Structure-selectivity investigations of D2-like receptor ligands by CoMFA and CoMSIA guiding the discovery of D3 selective PET radioligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

18F-Labeled FAUC 346 and BP 897 derivatives as subtype-selective potential PET radioligands for the dopamine D3 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Synthesis of new carbon-11-labeled carboxamide derivatives as potential PET dopamine D3 receptor radioligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Design, synthesis, and binding affinities of potential positron emission tomography (PET) ligands with optimal lipophilicity for brain imaging of the dopamine D3 receptor. Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part one: lead identification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Dopamine D(3) receptor antagonists: The quest for a potentially selective PET ligand. Part two: Lead optimization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part 3: Radiosynthesis and in vivo studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

A series of 18F-labelled pyridinylphenyl amides as subtype-selective radioligands for the dopamine D3 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Pharmacological modulation of functional connectivity: the correlation structure underlying the phMRI response to d-amphetamine modified by selective dopamine D3 receptor antagonist SB277011A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Imaging brain regional and cortical laminar effects of selective D3 agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

The identification of a selective dopamine D2 partial agonist, D3 antagonist displaying high levels of brain exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

[3-azabicyclo[3.1.0]hex-1-yl]phenyl-benzenesulfonamides as selective dopamine D3 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

The selective dopamine D3 receptor antagonist SB 277011-A, but not the partial agonist BP 897, blocks cue-induced reinstatement of nicotine-seeking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Evaluation of the D3 dopamine receptor selective antagonist PG01037 on L-dopa-dependent abnormal involuntary movements in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Delay of ejaculation induced by SB-277011, a selective dopamine D3 receptor antagonist, in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

GPCR targeted library design: novel dopamine D3 receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

7 January 2021

Generation of a set of simple, interpretable ADMET rules of thumb

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

7 January 2021

Plasma protein binding affinity and its relationship to molecular structure: an in-silico analysis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000538

7 January 2021

Identifiers

DOI

10.1002/CMDC.201000538

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425240%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425240%20AND%20SRC:MED&resulttype=core&format=json